2011-04-26T10:56:48-05:00 2010-12-31 JOHNSON LAMBERT & CO LLP 700 SPRING FOREST ROAD STE 115 RALEIGH NC 27609 990 2010-01-01 030466352 GYNECOLOGIC ONCOLOGY GROUP GYNE 4107217126 2127 ESPEY COURT NO 100 CROFTON MD 21114 MARY C SHARP 4107217126 2011-04-26 1 9197196400 2010 2016-02-24 21:20:13Z PHILIP J DISAIA MD 2127 ESPEY COURT NO 100 CROFTON MD 21114 37717055 0 X WWW.GOG.ORG X 2002 DC THE GYNECOLOGIC ONCOLOGY GROUP'S PRIMARY EXEMPT PURPOSE IS TO PROMOTE EXCELLENCE IN THE QUALITY AND INTEGRITY OF CLINICAL AND BASIC SCIENTIFIC RESEARCH IN THE FIELD OF GYNECOLOGIC MALIGNANCIES. 13 12 32 0 0 0 15606369 19305875 8803347 10347487 601660 890471 5875 73224 25017251 30617057 0 0 0 0 2581039 2666022 0 0 243059 19811754 20697878 22392793 23363900 2624458 7253157 27081337 33127477 8668149 6146769 18413188 26980708 X THE GYNECOLOGIC ONCOLOGY GROUP (GOG) IS A NON-PROFIT ORGANIZATION (NATIONAL) WITH THE PURPOSE OF PROMOTING EXCELLENCE IN THE QUALITY AND INTEGRITY OF CLINICAL AND BASIC SCIENTIFIC RESEARCH IN THE FIELD OF GYNECOLOGIC MALIGNANCIES. THE GROUP (GYNECOLOGIC ONCOLOGISTS, MEDICAL ONCOLOGISTS, PATHOLOGISTS, RADIATION ONCOLOGISTS, NURSES, STATISTICIANS, BASIC SCIENTISTS, QUALITY OF LIFE EXPERTS, DATA MANAGERS AND ADMINISTRATIVE PERSONNEL) IS COMMITTED TO MAINTAINING THE HIGHEST STANDARDS IN CLINICAL TRIALS DEVELOPMENT, EXECUTION, ANALYSIS AND DISTRIBUTION OF RESULTS. CONTINUOUS EVALUATION OF OUR PROCESSES IS UTILIZED IN ORDER TO CONSTANTLY IMPROVE THE QUALITY OF PATIENT CARE. 0 0 23117899 10347487 THE GROUP IS COMMITTED TO MAINTAINING THE HIGHEST STANDARDS IN CLINICAL TRIALS DEVELOPMENT, EXECUTION, ANALYSIS AND DISTRIBUTION OF RESULTS. CONTINUOUS EVALUATION OF OUR PROCESSES IS UTILIZED IN ORDER TO CONSTANTLY IMPROVE THE QUALITY OF PATIENT CARE. IN 2010 GYNECOLOGIC ONCOLOGY GROUP CONDUCTED CLINICAL TRIALS THROUGH OUR 60 PLUS MEMBER INSTITUTIONS. THESE EXPENSES INCLUDED PROTOCOL DEVELOPMENT, REGULATORY AFFAIRS, MEETINGS TO REVIEW TRIAL DATA, TRIAL DEVELOPMENT THROUGH COMMITTEE FUNCTIONS AND OTHER INDIRECT RELATED EXPENSES. 23117899 1 1 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 52 0 1 32 1 0 0 0 0 0 0 0 0 0 0 X 13 12 0 0 0 0 1 1 0 1 1 0 0 0 1 1 1 1 1 1 1 0 MD X MARY C SHARP CFO 4107217126 2127 ESPEY COURT SUITE 100 CROFTON MD 21114 PHILIP J DISAIA MD 20.00 X X 0 0 0 LARRY J COPELAND MD 13.00 X X 0 0 0 ROBERT C PARK MD 1.00 X 0 0 0 D SCOTT MCMEEKIN MD 1.00 X X 0 0 0 JOEL SOROSKY MD 1.00 X 0 0 0 RONALD ALVAREZ MD 1.00 X 0 0 0 STEVEN WAGGONER MD 1.00 X 0 0 0 JOHN BLESSING PHD 1.00 X 0 0 0 ROBERT A BURGER MD 1.00 X 0 0 0 GINI FLEMING MD 1.00 X 0 0 0 HEESUN KIM-SUH RN 1.00 X 0 0 0 AARON WOLFSON MD 1.00 X 0 0 0 WILLIAM H RODGERS PHD 1.00 X 0 0 0 MARY C SHARP 35.00 X 192226 0 39185 LAURA REESE 35.00 X 153739 0 16787 DENISE MACKEY 35.00 X 119789 0 19005 KATHY SHUMAKER 35.00 X 105024 0 30464 570778 0 105441 4 0 1 0 0 17999979 1305896 19305875 INDUSTRY REVENUE 900099 10011412 10011412 REGISTRATION FEES 900099 291575 291575 EXHIBIT FESS 900099 44500 44500 10347487 840561 840561 7149908 7099998 49910 49910 49910 MISCELLANEOUS 900099 73224 73224 73224 30617057 10347487 0 963695 401936 385859 16077 1655149 1039454 496054 119641 165520 103315 50144 12061 297879 205933 70052 21894 145538 102085 33506 9947 19276 19276 21114 1397 19717 286305 170394 115911 1800 1800 256236 172293 65666 18277 21492 2190 19302 257568 193328 64240 491435 422286 55017 14132 632376 397258 213358 21760 22784 22784 PURCHASE SERVICE AGREEM 11085689 11085689 CONSORTIUMS 7304630 7281973 22657 MISCELLANEOUS 244765 192762 51166 837 HONORARIA 43779 7000 30146 6633 DUES AND SUBSCRIPTIONS 8629 4042 4587 1350641 -1350641 23363900 23117899 2942 243059 47838 123256 4144131 3560904 2513309 1845294 62692 66260 20280453 27498271 32914 33492 27081337 33127477 3941384 2018399 4726765 4128370 8668149 6146769 X 18413188 26980708 18413188 26980708 27081337 33127477 X 7253157 1314363 X 0 1 1 X 1 1 X 15941171 15344262 12791134 15606369 19305875 78988811 15941171 15344262 12791134 15606369 19305875 78988811 78988811 632297 1103186 434608 570476 840561 3581128 1726 24605 101337 5875 73224 206767 82776706 29297117 0.95420 0.97320 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 30617057 23363900 7253157 1314363 1314363 8567520 31931420 1314363 1314363 30617057 0 30617057 23363900 0 23363900 0 23363900 DESCRIPTION OF UNCERTAIN TAX POSITIONS UNDER FIN 48: PART X: MANAGEMENT HAS CONCLUDED THAT GOG HAS PROPERLY MAINTAINED ITS EXEMPT STATUS, AND THERE ARE NO UNCERTAIN TAX POSITIONS AS OF DECEMBER 31, 2010 OR 2009. X X 0 0 0 0 0 0 0 0 0 MARY C SHARP 188976 0 3250 0 0 0 19223 0 19962 0 231411 0 0 0 LAURA REESE 150489 0 3250 0 0 0 15374 0 1413 0 170526 0 0 0 PHILLIP J DISAIA PRESIDENT 29955 CONSULTING AGREEMENT 0 FORM 990, PART VI, SECTION A, LINE 6 GOG IS A MEMBERSHIP ORGANIZATION. CLASSES OF MEMBERS ARE AS FOLLOWS: INSTITUTIONAL FULL MEMBERS, INSTITUTIONAL PROVISIONAL MEMBERS, INSTITUTIONAL PROBATIONARY MEMBERS, AND INDIVIDUAL MEMBERS. OF THESE, INSTITUTIONAL FULL MEMBERS ARE THE ONLY CLASS THAT CAN VOTE. FORM 990, PART VI, SECTION A, LINE 7A INSTITUTIONAL FULL MEMBERS ELECT THE MEMBERS OF THE BOARD BY MAJORITY VOTE. FORM 990, PART VI, SECTION B, LINE 11 FORM 990 IS REVIEWED BY THE CFO BEFORE FILING. FORM 990, PART VI, SECTION B, LINE 12C CONFLICT OF INTEREST DISCLOSURE FORMS ARE REVIEWED ANNUALLY BY THE GROUP CHAIR, AND ON AN INTERIM BASIS. THE GROUP CHAIR REVIEWS ANNUAL FORMS NO LATER THAN NOVEMBER 1 OF EACH YEAR, AND INTERIM FORMS WITHIN 30 DAYS. THE CONFLICT IS MANAGED, REDUCED, OR ELIMINATED, AT LEAST ON AN INTERIM BASIS, WITHIN 60 DAYS OF ITS IDENTIFICATION. FORM 990, PART VI, SECTION B, LINE 15 OFFICER AND KEY EMPLOYEE SALARY IS APPROVED BY THE BOARD OF DIRECTORS ANNUALLY, IN CONSULTATION WITH A COMPENSATION SURVEY WHICH IS OBTAINED PERIODICALLY. FORM 990, PART VI, SECTION C, LINE 19 GOVERNING DOCUMENTS, POLICIES, AND FINANCIAL STATEMENTS ARE MADE AVAILABLE AT RECEPTIONIST'S DESK. CHANGES IN NET ASSETS OR FUND BALANCES: FORM 990, PART XI, LINE 5: NET UNREALIZED GAINS (LOSSES) ON INVESTMENTS 1,314,363. TOTAL TO FORM 990, PART XI, LINE 5: 1,314,363.